Codexis Inc
Открыт
СекторЗдравоохранение
2.56 4.07
Обзор
Изменение цены акций
24 ч
Мин.
2.5300000000000002
Макс.
2.63
Доход | -18M -8.7M |
|---|---|
Продажи | -24M 15M |
Прибыль на акцию | -0.1 |
Рентабельность продаж | -57.083 |
Сотрудники | 146 |
EBITDA | -23M -6.4M |
Рекомендации | Активная покупка |
|---|---|
Прогноз на 12 месяцев | +178.23% upside |
Следующий отчет о доходах | 12 авг. 2026 г. |
|---|
Рыночная капитализация | -1.8M 226M |
|---|---|
Предыдущая цена открытия | -1.51 |
Предыдущая цена закрытия | 2.56 |
Новостные настроения
By Acuity
50%
50%
140 / 342 Рейтинг в Healthcare
Codexis Inc График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании Codexis Inc
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
